Filing Details
- Accession Number:
- 0001562180-21-007616
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-09 18:42:11
- Reporting Period:
- 2021-12-07
- Accepted Time:
- 2021-12-09 18:42:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1636422 | Health Catalyst Inc. | HCAT | Services-Computer Programming, Data Processing, Etc. (7370) | 453337483 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1780980 | D. Daniel Burton | C/O Health Catalyst, Inc. 10897 South River Front Parkway, #300 South Jordan UT 84095 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-07 | 15,530 | $10.80 | 252,436 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-12-07 | 15,530 | $40.47 | 236,906 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-12-07 | 15,530 | $0.00 | 15,530 | $10.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 157,743 | 2028-09-27 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2021, in accordance with Rule 10b5-1.
- Represents the weighted average sale price of the shares sold ranging from $40.14 to $40.75 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- 25% of the 747,223 shares underlying the option vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.
Billionaire Hedge Funds
